IYH:NYE-iShares U.S. Healthcare ETF (USD)

ETF | Health |

Last Closing

USD 64.5

Change

-0.12 (-0.19)%

Market Cap

N/A

Volume

0.17M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.31 (-0.20%)

USD 41.71B
FHLC Fidelity® MSCI Health Care In..

-0.08 (-0.11%)

USD 2.97B
FXH First Trust Health Care AlphaD..

-0.78 (-0.71%)

USD 1.29B
XHE SPDR® S&P Health Care Equipme..

-0.33 (-0.37%)

USD 0.22B
IDNA iShares Genomics Immunology an..

+0.03 (+0.12%)

USD 0.14B
SBIO ALPS Medical Breakthroughs ETF

+0.02 (+0.06%)

USD 0.11B
XHS SPDR® S&P Health Care Service..

-0.11 (-0.12%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.02 (-0.06%)

USD 0.06B
BBP Virtus LifeSci Biotech Product..

+0.70 (+1.13%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.05 (+0.18%)

USD 0.01B

ETFs Containing IYH

RXD ProShares UltraShort Heal.. 10.32 % 0.77 %

+0.01 (+0.15%)

N/A
RXD ProShares UltraShort Heal.. 10.32 % 0.95 %

+0.01 (+0.15%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.67% 81% B- 64% D
Dividend Return 0.92% 75% C 16% F
Total Return 13.59% 86% B+ 59% D-
Trailing 12 Months  
Capital Gain 20.40% 57% F 53% F
Dividend Return 1.31% 72% C 16% F
Total Return 21.71% 57% F 47% F
Trailing 5 Years  
Capital Gain 70.63% 90% A- 77% C+
Dividend Return 6.82% 78% C+ 20% F
Total Return 77.45% 90% A- 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.12% N/A N/A 66% D+
Dividend Return 10.13% N/A N/A 62% D
Total Return 1.01% N/A N/A 23% F
Risk Return Profile  
Volatility (Standard Deviation) 12.64% N/A N/A 71% C-
Risk Adjusted Return 80.10% N/A N/A 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike